GL1X · GenesisL1 explorer

MolNFT v1 · #157945 · protein

Btk in complex with inhibitor 8-(2,3-dihydro-1H-inden-5-yl)-2-({4- [(2S)-3-(dimethylamino)-2-HYDROXYPROPOXY]PHENYL}AMINO)-5,8- dihydropteridine-6,7-dione

6NFH · Tyrosine-protein kinase btk: “Btk in complex with inhibitor 8-(2,3-dihydro-1H-inden-5-yl)-2-({4…”. X-ray diffraction, 1 ligand (KLM), 2 pockets (best druggability 0.69). MolNFT v1 #157945 on GenesisL1: 3D structure, binding sites…

PDB
6NFH
Type
protein
Length
271 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
KLM
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein27141% helix, 17% strandQ06187

Ligands and binding sites

  • KLM · 8-(2,3-dihydro-1H-inden-5-yl)-2-({4-[(2S)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14580.690.8058KLM, EDO
21000.390.7619EDO

Compared structures

  • 6NFH · BTK in complex with inhibitor 8-(2,3-dihydro-1H-inden-5-yl)-2-({4-[(2S)-3-(dimethylamino)… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.